Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.
Barclays keeps Overweight rating and $9 price target on Sangamo (SGMO), noting that while Pfizer’s (PFE) decision to discontinue HemoA gene therapy came as a big surprise given the prior ...
(RTTNews) - Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to accelerate the discovery of novel precision ...
Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 ...
Pfizer CEO met RFK Jr. and Trump, developed good relationship Trump committed to reforming pharmacy benefit managers, reducing medicine costs Pfizer faces investor pressure over strategy, shares ...
Pfizer (NYSE:PFE) just dropped some solid news for investors: 2025 revenue projections are right where Wall Street expected, between $61 billion and $64 billion, with adjusted earnings per share ...
Beata Zawrzel / NurPhoto via Getty Images Pfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.
Pfizer (PFE, Financial) has said it expects its 2025 revenue and earnings to match market consensus, even as it predicts such a redesign of federal drug benefits will hit it with a $1 billion hit.
Goldman Sachs projects Pfizer’s 2025 EPS at $3.13, beating consensus of $2.89. Paxlovid sales expected to reach $4.3 billion vs. consensus of $3.7 billion; Vyndaqel forecast misses. Pfizer Inc ...
Pfizer forecast 2025 revenue and earnings in ... and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity of our editorial content, we keep ...
After successfully meeting its fourth-quarter targets, Pfizer has expressed optimism about its financial outlook for the upcoming fiscal year. On Tuesday, Pfizer’s stock rose following the ...